In the CNS LS-related tumor group in our study, the MSH2 gene (42.65%) accounted for the greatest proportion of the four MMR germline P/LP genes, which is consistent with previous reports and highlights the importance of screening for the MSH2 gene in CNS tumors25,28. This evidence concerns the gene MRC1 and neoplasm.